Oncology Expert Presented Prostate Cancer Care Guidelines
New guidance helps men navigate screening and genetic risk factors for prostate cancer.
Updated on Oct. 5, 2026 in Cancer
Live Poll
Do you plan to schedule regular cancer screenings this year to ensure early detection?
On September 15-16, 2026, Frank dela Rama presented a guide for oncology nurses on managing prostate cancer care. The session focused on the critical role of screening, genetic assessment, and risk stratification for patients.
Why it matters
Understanding personal risk, specifically regarding family history and genetic variants, is vital for early detection and improving treatment outcomes. Early intervention is essential because the survival rate drops significantly once the cancer reaches a distant stage.
Clinical data presented showed that the 5-year survival rate for localized prostate cancer is nearly 100%, compared to 38% for distant-stage disease. While baseline risk for males is 12%, specific genetic variants and family history significantly alter individual risk profiles.
The players
Frank dela Rama
An oncology expert affiliated with the Sutter Health Medical Foundation who specializes in cancer care coordination.
The details
Prostate cancer management involves risk stratification through PSA blood tests, digital rectal exams, Gleason Grade Group assessments, and tumor staging. Nurses support patients by coordinating care, managing symptoms, and providing education on complex topics like germline genetic testing, which may include assessment of BRCA1, BRCA2, ATM, PALB2, and CHEK2 genes.
Timeline
Frank dela Rama presented at ONS Bridge 2026 on September 15-16, 2026.
Health Landscape
The ONS Bridge conference serves as a major forum for oncology nurses to update clinical standards for common malignancies. These efforts follow a growing trend of integrating germline genetic testing into routine oncology care for high-risk populations.
Most prostate cancer cases occur in men over 65, making it a critical topic for regular discussions with your primary care physician. If you have a first-degree relative with a history of prostate cancer, consider discussing your risk factors and the appropriate age to begin screening with your doctor.
The takeaway
Prostate cancer survival is highly dependent on early detection, as survival rates remain high when the disease is localized. Prioritize a conversation with your physician regarding your family history and whether genetic counseling or specific screenings are appropriate for your health profile.
Further reading
For more information on screening and risk factors, visit our Cancer section.
Source note: This article includes information reported by Renal and Urology News.
Live Poll
Do you plan to schedule regular cancer screenings this year to ensure early detection?
